Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Price to Earnings (2010 - 2026)

Lite Strategy (LITS) posted Price to Earnings of 1.89 for Q1 2026, down 17.49% on a QoQ basis from 1.61 in Q4 2025, and up 66.65% year-over-year from 1.14 in Q1 2025.

Analysis

Lite Strategy (LITS) Price to Earnings (2010 - 2026) Analysis & Trends

Lite Strategy has reported Price to Earnings for 17 years, with the latest figure at 1.89 in Q1 2026.

  • On a quarterly basis, Price to Earnings rose 66.65% year-over-year to 1.89 in Q1 2026; TTM through Mar 2026 was 0.71, a 55.57% decrease from a year earlier, with the FY2025 full-year figure at 1.0, down 192.06% from the prior year.
  • Price to Earnings was 1.89 for Q1 2026 at Lite Strategy, down from 1.61 in the prior quarter.
  • The five-year high for Price to Earnings was 3.27 in Q4 2022, with the low at 19.6 in Q3 2025.
  • Average Price to Earnings over 5 years is 3.76, with a median of 2.93 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Price to Earnings soared 128.28% in 2023, then sank 725.47% in 2025.
  • Over 5 years, Price to Earnings stood at 3.27 in 2022, then tumbled by 206.74% to 3.49 in 2023, then sank by 47.9% to 5.17 in 2024, then jumped by 68.84% to 1.61 in 2025, then slipped by 17.49% to 1.89 in 2026.
  • The last three Price to Earnings figures came in at 1.89 (Q1 2026), 1.61 (Q4 2025), and 19.6 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.89
Dec 31, 2025 -1.61
Sep 30, 2025 -19.60
Jun 30, 2025 -6.12
Mar 31, 2025 -5.67
Dec 31, 2024 -5.17
Sep 30, 2024 -2.37
Jun 30, 2024 -1.06
Mar 31, 2024 -2.92
Dec 31, 2023 -3.49
Sep 30, 2023 0.83
Jun 30, 2023 -4.38
Mar 31, 2023 -1.99
Dec 31, 2022 3.27
Sep 30, 2022 -2.93
Jun 30, 2022 -5.08
Mar 31, 2022 -3.72
Dec 31, 2021 -20.15
Sep 30, 2021 -15.47
Jun 30, 2021 -20.76